Neonatal Thyroxine Supplementation in Very Preterm Children: Developmental Outcome Evaluated at Early School Age

Transient hypothyroxinemia in very premature infants is associated with developmental problems. A randomized, placebo-controlled trial of thyroxine (T(4)) supplementation was conducted in a group of 200 infants

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 2001-04, Vol.107 (4), p.712-718
Main Authors: Briet, Judy M, van Wassenaer, Aleid G, Dekker, Friedo W, de Vijlder, Jan J. M, van Baar, Anneloes, Kok, Joke H
Format: Article
Language:English
Subjects:
Biological and medical sciences
Care and treatment
Child
Child Development - drug effects
Child Development - physiology
Child, Preschool
Developmental Disabilities - diagnosis
Developmental Disabilities - prevention & control
Follow-Up Studies
Gestational Age
Health aspects
Hormones. Endocrine system
Humans
Hypothyroidism
Hypothyroidism - diagnosis
Hypothyroidism - prevention & control
Infant
Infant, Newborn
Infant, Premature - blood
Infant, Premature - growth & development
Infants (Premature)
Medical sciences
Neuropsychological Tests
Pharmacology. Drug treatments
Premature infants
Thyroxine
Thyroxine - administration & dosage
Thyroxine - blood
Thyroxine - therapeutic use
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transient hypothyroxinemia in very premature infants is associated with developmental problems. A randomized, placebo-controlled trial of thyroxine (T(4)) supplementation was conducted in a group of 200 infants
ISSN:0031-4005
1098-4275
DOI:10.1542/peds.107.4.712